mercilon tablette
a.s unicare pharma-vertriebs-gmbh - ethinylestradiol, desogestrel - tablette - ethinylestradiol 0.02mg; desogestrel 0.15mg
mercilon tablette
gpp pharma arzneimittelvertriebsgesellschaft mbh - ethinylestradiol, desogestrel - tablette - ethinylestradiol 0.02mg; desogestrel 0.15mg
mercilon - tabletten
eurim-pharm vertriebs-gmbh & co kg - desogestrel; ethinylestradiol -
benifema 150 mikrogramm/30 mikrogramm filmtabletten
actavis group ptc ehf - desogestrel; ethinylestradiol -
mercilon
beragena arzneimittel gmbh (3247528) - ethinylestradiol; desogestrel - tablette - teil 1 - tablette; ethinylestradiol (02200) 0,02 milligramm; desogestrel (19118) 0,15 milligramm
mercilon
a.c.a. müller adag pharma aktiengesellschaft (8049833) - ethinylestradiol; desogestrel - tablette - 0,15 mg/0,02 mg - teil 1 - tablette; ethinylestradiol (02200) 0,02 milligramm; desogestrel (19118) 0,15 milligramm
mercilon tablette
pharma service grünewald gmbh - ethinylestradiol, desogestrel - tablette - ethinylestradiol 0.02mg; desogestrel 0.15mg
opatanol
novartis europharm limited - olopatadinhydrochlorid - konjunktivitis, allergisch - ophthalmika - behandlung von augenzeichen und symptomen der saisonalen allergischen konjunktivitis.
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asthma - medikamente für obstruktive atemwegserkrankungen, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - asthma - medikamente für obstruktive atemwegserkrankungen, - maintenance treatment of asthma in adults whose disease is not adequately controlled.